首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1136998

日光角化症市场:治疗方法，各终端用户，各地区- 规模，占有率，展望，机会分析，2022年～2030年

Actinic Keratosis Market, by Treatment (Medication, Surgical Procedure, Photodynamic Therapy, Combination Therapies, By End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年08月26日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

简介目录

市场动态

预计监管机构批准的光化性角化病治疗药物数量的增加将推动预测期内全球光化性角化病市场的增长。

本调查的主要特征

本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球日光角化症市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球日光角化症市场的主要参与者之企业简介。
藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球日光角化症市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以透过全球日光角化症市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

企业简介
- Almirall,S.A.
- Bausch Health Companies Inc.
- Perrigo Company plc.
- Sun Pharmaceutical Industries Ltd.
- Hill Dermaceuticals, Inc.
- Spear Pharmaceuticals
- Tolmar Pharmaceuticals, Inc.
- Biofrontera AG
- Cipher Pharmaceuticals Inc.
- Vidac
- Athenex, Inc.
- 3M
- Mayne Pharma Group Limited

第9章章节

参考文献
调查手法

简介目录

Product Code: CMI1006

Actinic Keratosis (AK) is the most common pre-cancer that forms on skin damaged by chronic exposure to ultraviolet (UV) rays from the sun. Actinic Keratosis is also known as solar keratosis. Actinic keratosis forms like a patch on the skin. The patches usually appear on areas of your body that are often exposed to the sun, such as your face, hands and arms, ears, scalp and legs. Sometimes actinic keratosis can turn into squamous cell skin cancer. For this reason, the lesions are often called pre-cancer. Patches are not life-threatening. But if patches are found and treated early, they do not have the chance to develop into skin cancer. Actinic Keratosis can affect:

People with pale skin, blonde or red hair, and blue, green, or gray eyes
People with darker skin, hair, and eyes who have been exposed to UV rays without protection
Older adults
People with suppressed immune systems (due to chemotherapy, AIDS, organ transplant, or other causes)
People with rare conditions that make the skin very sensitive to UV rays, such as albinism or xeroderma pigmentosum (XP)

Market Dynamics

Increasing number of drug approvals for the treatment of actinic keratosis from regulatory bodies is expected to drive growth of the global actinic keratosis market during the forecast period. For instance, In November 2017, Perrigo Company plc, an Ireland based healthcare company, had announced that the company had received tentative approval from the U.S. Food and Drug Administration (FDA) for the generic version of Picato Gel (ingenol mebutate) 0.05%. It is indicated for the topical treatment of actinic keratosis.

High incidence rate of skin cancer is expected to drive growth of the global actinic keratosis market. For instance, according to American Academy of Dermatology Association 2022, Skin cancer is the most common cancer in the U.S. It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day. It is estimated that the overall incidence of basal cell carcinoma (BCC) increased by 145% between 1976-1984 and between 2000-2010, and the overall incidence of squamous cell carcinoma (SCC) increased 263% over that same period.

Key features of the study:

This report provides an in-depth analysis of global actinic keratosis market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global actinic keratosis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include Almirall, S.A., Bausch Health Companies Inc., Perrigo Company plc., Sun Pharmaceutical Industries Ltd., Hill Dermaceuticals Inc., Spear Pharmaceuticals, Tolmar Pharmaceuticals Inc., Biofrontera AG., Cipher Pharmaceuticals Inc., Vidac, Athenex, Inc., 3M, and Mayne Pharma Group Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global actinic keratosis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global actinic keratosis

Detailed Segmentation:

Global Actinic Keratosis Market, By Treatment:
- Medication
- Surgical Procedure
  - Chemical peel
  - Cryosurgery
  - Curettage and desiccation
  - Laser surgery
- Photodynamic Therapy
- Combination Therapies
  - Cryosurgery and PDT
  - Cryosurgery and a topical treatment
  - Topical treatments and PD
Global Actinic Keratosis Market, By End User:
- Hospitals & Specialty Clinics
- Homecare
Global Actinic Keratosis Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Almirall, S.A*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Bausch Health Companies Inc.
- Perrigo Company plc
- Sun Pharmaceutical Industries Ltd.
- Hill Dermaceuticals, Inc.
- Spear Pharmaceuticals
- Tolmar Pharmaceuticals, Inc.
- Biofrontera AG
- Cipher Pharmaceuticals Inc.
- Vidac
- Athenex, Inc.
- 3M
- Mayne Pharma Group Limited

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Treatment
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Industry Trends
PEST Analysis
Pipeline Analysis
Key Development
Regulatory Scenario
Epidemiology
Overview of Treatment Guidelines for Actinic Keratosis

4. Global Actinic Keratosis Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Supply and Demand Analysis

5. Global Actinic Keratosis Market, By Treatment, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Surgical Procedure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Chemical peel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Cryosurgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Photodynamic Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Combination Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Cryosurgery and PDT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Cryosurgery and a topical treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Topical treatments and PD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

6. Global Actinic Keratosis Market, By End User, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospitals and Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Homecare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Actinic Keratosis Market, By Region, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2030
- Regional Trends
North America
- Market Size and Forecast, By Treatment, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Treatment, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Treatment, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Treatment, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Treatment, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Treatment, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
South Africa
Central Africa
North Africa

8. Competitive Landscape

Company Profiles
- Almirall,S.A.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Bausch Health Companies Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Perrigo Company plc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Sun Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Hill Dermaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Spear Pharmaceuticals
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Tolmar Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Biofrontera AG
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Cipher Pharmaceuticals Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Vidac
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Athenex, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- 3M
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Mayne Pharma Group Limited
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Analyst Views

9. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

日光角化症市场:治疗方法，各终端用户，各地区- 规模，占有率，展望，机会分析，2022年～2030年

Actinic Keratosis Market, by Treatment (Medication, Surgical Procedure, Photodynamic Therapy, Combination Therapies, By End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

市场动态

本调查的主要特征

目录

第1章调查目的与前提条件

第2章市场概要

第3章市场动态，法规，趋势分析

第4章光化性角化症的全球市场:冠状病毒(COVID-19)疫情的影响

第5章光化性角化症的全球市场:不同治疗，2017-2030年

第6章光化性角化症的全球市场，各终端用户，2017年～2030年

第7章光化性角化症的全球市场:各地区，2017年～2030年

第8章竞争情形

第9章章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Actinic Keratosis Market- Impact of Coronavirus (Covid-19) Pandemic

5. Global Actinic Keratosis Market, By Treatment, 2017-2030 (US$ Million)

6. Global Actinic Keratosis Market, By End User, 2017-2030 (US$ Million)

7. Global Actinic Keratosis Market, By Region, 2017 - 2030 (US$ Million)

8. Competitive Landscape

9. Section

日光角化症市场:治疗方法，各终端用户，各地区- 规模，占有率，展望，机会分析，2022年～2030年

Actinic Keratosis Market, by Treatment (Medication, Surgical Procedure, Photodynamic Therapy, Combination Therapies, By End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

市场动态

本调查的主要特征

目录

第1章 调查目的与前提条件

第2章 市场概要

第3章 市场动态，法规，趋势分析

第4章 光化性角化症的全球市场:冠状病毒(COVID-19)疫情的影响

第5章 光化性角化症的全球市场:不同治疗，2017-2030年

第6章 光化性角化症的全球市场，各终端用户，2017年～2030年

第7章 光化性角化症的全球市场:各地区，2017年～2030年

第8章 竞争情形

第9章 章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Actinic Keratosis Market- Impact of Coronavirus (Covid-19) Pandemic

5. Global Actinic Keratosis Market, By Treatment, 2017-2030 (US$ Million)

6. Global Actinic Keratosis Market, By End User, 2017-2030 (US$ Million)

7. Global Actinic Keratosis Market, By Region, 2017 - 2030 (US$ Million)

8. Competitive Landscape

9. Section

第1章调查目的与前提条件

第2章市场概要

第3章市场动态，法规，趋势分析

第4章光化性角化症的全球市场:冠状病毒(COVID-19)疫情的影响

第5章光化性角化症的全球市场:不同治疗，2017-2030年

第6章光化性角化症的全球市场，各终端用户，2017年～2030年

第7章光化性角化症的全球市场:各地区，2017年～2030年

第8章竞争情形

第9章章节